Antonio Cano Sanchez
Joaquim Calaf i Alsina
José-Luis Dueñas-Díez
(Editors)

2006

A New Brand of Multitarget Drugs

The increasing awareness on the varied consequences of hypogonadism in distinct organs and systems has supported the notion of estrogens as systemic agents. This observation is congruent with the variety of tissues affected by estrogens when used in hormone therapy formulations on hypogonadic women.